Vedanta signs licence agreement with Japanese researchers

Vedanta Biosciences has struck a licence deal with Japanese research institution RIKEN, the University of Tokyo and Azabu University for new immune boosting microbiome technology.

The technology was developed by RIKEN team leader and Vedanta co-founder and scientific advisory board member Dr Kenya Honda. It has potential clinical applications in infectious disease, vaccine design and immuno-oncology.

Vedanta also received a second patent issuance in Japan for key intellectual property.